158 related articles for article (PubMed ID: 27340350)
1. Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy.
Liu T; Wu HJ; Liang Y; Liang XJ; Huang HC; Zhao YZ; Liao QC; Chen YQ; Leng AM; Yuan WJ; Zhang GY; Peng J; Chen YH
World J Gastroenterol; 2016 Jun; 22(23):5342-52. PubMed ID: 27340350
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-delivered VEGF-silencing cassette and suicide gene expression cassettes inhibit colon carcinoma growth in vitro and in vivo.
Leng A; Yang J; Liu T; Cui J; Li XH; Zhu Y; Xiong T; Chen Y
Tumour Biol; 2011 Dec; 32(6):1103-11. PubMed ID: 21761115
[TBL] [Abstract][Full Text] [Related]
3. Combination gene therapy using VEGF-shRNA and fusion suicide gene yCDglyTK inhibits gastric carcinoma growth.
Liu T; Ye L; He Y; Chen X; Peng J; Zhang X; Yi H; Peng F; Leng A
Exp Mol Pathol; 2011 Dec; 91(3):745-52. PubMed ID: 21840308
[TBL] [Abstract][Full Text] [Related]
4. Calcium phosphate nanoparticles as a novel nonviral vector for efficient transfection of DNA in cancer gene therapy.
Liu T; Tang A; Zhang G; Chen Y; Zhang J; Peng S; Cai Z
Cancer Biother Radiopharm; 2005 Apr; 20(2):141-9. PubMed ID: 15869447
[TBL] [Abstract][Full Text] [Related]
5. Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo.
Zhang G; Liu T; Chen YH; Chen Y; Xu M; Peng J; Yu S; Yuan J; Zhang X
Clin Cancer Res; 2009 Jan; 15(1):201-7. PubMed ID: 19118047
[TBL] [Abstract][Full Text] [Related]
6. [Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].
Wang J; Zhang ZZ; Zhou TY; Liu YQ; Li HX
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):566-72. PubMed ID: 19102931
[TBL] [Abstract][Full Text] [Related]
7. Tissue specific expression of suicide genes delivered by nanoparticles inhibits gastric carcinoma growth.
Liu T; Zhang G; Chen YH; Chen Y; Liu X; Peng J; Xu MH; Yuan JW
Cancer Biol Ther; 2006 Dec; 5(12):1683-90. PubMed ID: 17224635
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter.
Zhang P; Chen Y; Jiang X; Tu Z; Zou L
Oncol Rep; 2010 May; 23(5):1309-16. PubMed ID: 20372845
[TBL] [Abstract][Full Text] [Related]
9. A novel fusion suicide gene yeast CDglyTK plays a role in radio-gene therapy of nasopharyngeal carcinoma.
Xia K; Liang D; Tang A; Feng Y; Zhang J; Pan Q; Long Z; Dai H; Cai F; Wu L; Zhao S; Chen Z; Xia J
Cancer Gene Ther; 2004 Dec; 11(12):790-6. PubMed ID: 15499380
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.
Zhang MX; Hong SS; Cai QQ; Zhang M; Chen J; Zhang XY; Xu CJ
Drug Deliv; 2018 Nov; 25(1):797-806. PubMed ID: 29542355
[TBL] [Abstract][Full Text] [Related]
11. VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.
Yoo JY; Kim JH; Kwon YG; Kim EC; Kim NK; Choi HJ; Yun CO
Mol Ther; 2007 Feb; 15(2):295-302. PubMed ID: 17235307
[TBL] [Abstract][Full Text] [Related]
12. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
13. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects.
Li J; Zhang G; Liu T; Gu H; Yan L; Chen B
Exp Ther Med; 2012 Sep; 4(3):442-448. PubMed ID: 23181115
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
[TBL] [Abstract][Full Text] [Related]
16. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
[TBL] [Abstract][Full Text] [Related]
18. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
19. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
20. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Cancer Chemother Pharmacol; 2006 Feb; 57(3):328-34. PubMed ID: 16028098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
